The Pennant Group (PNTG) and Its Competitors Financial Review

The Pennant Group (NASDAQ:PNTG) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its competitors? We will compare The Pennant Group to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

Valuation & Earnings

This table compares The Pennant Group and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
The Pennant Group	$947.71 million	$29.58 million	36.90
The Pennant Group Competitors	$21.44 billion	$301.67 million	6.82

The Pennant Group’s competitors have higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Volatility & Risk

The Pennant Group has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Comparatively, The Pennant Group’s competitors have a beta of 0.98, meaning that their average stock price is 2% less volatile than the S&P 500.

Profitability

This table compares The Pennant Group and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
The Pennant Group	3.05%	10.23%	4.06%
The Pennant Group Competitors	-8.06%	-138.13%	-1.54%

Analyst Recommendations

This is a summary of current ratings for The Pennant Group and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0	1	6	0	2.86
The Pennant Group Competitors	1867	7737	13362	823	2.55

The Pennant Group presently has a consensus target price of $48.00, suggesting a potential upside of 31.40%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.63%. Given The Pennant Group’s stronger consensus rating and higher possible upside, equities research analysts clearly believe The Pennant Group is more favorable than its competitors.

Institutional & Insider Ownership

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

The Pennant Group beats its competitors on 9 of the 13 factors compared.

The Pennant Group Company Profile

The Pennant Group, Inc. provides healthcare and senior living services through independently operated subsidiaries. Its services include home health and hospice care for people in their homes, as well as senior living options such as assisted living and memory care. Based in Eagle, Idaho, the company operates across multiple U.S. states, with a presence concentrated in the western part of the country. Its local operating teams provide care and support to patients, residents and their families. Pennant became an independent publicly traded company in 2019 after separating from The Ensign Group.